Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Jeroen J. van den Broek"'
Autor:
Elizabeth S. Burnside MD, MPH, MS, Sandra J. Lee ScD, Carrie Bennette PhD, Aimee M. Near MPH, Oguzhan Alagoz PhD, Hui Huang MS, Jeroen J. van den Broek MS, Joo Yeon Kim MS, Mehmet A. Ergun MSc, Nicolien T. van Ravesteyn PhD, Natasha K. Stout PhD, Harry J. de Koning MD, PhD, Jeanne S. Mandelblatt MD, MPH
Publikováno v:
MDM Policy & Practice, Vol 2 (2017)
Background: There are no publicly available tools designed specifically to assist policy makers to make informed decisions about the optimal ages of breast cancer screening initiation for different populations of US women. Objective: To use three est
Externí odkaz:
https://doaj.org/article/0d0f6a6941044140bf9b71056526cbcd
Autor:
John M. Hampton, Jeanne S. Mandelblatt, Amy Trentham-Dietz, Brian L. Sprague, Jeroen J. van den Broek, Clyde B. Schechter, Diana L. Miglioretti, Karla Kerlikowske, Nicolien T. van Ravesteyn, Natasha K. Stout, Harry J. de Koning, Anna N.A. Tosteson, Oguzhan Alagoz
Publikováno v:
Journal of the National Cancer Institute, 113(8), 1017-1026. Oxford University Press
JNCI Journal of the National Cancer Institute
Journal of the National Cancer Institute, vol 113, iss 8
JNCI Journal of the National Cancer Institute
Journal of the National Cancer Institute, vol 113, iss 8
Background A paucity of research addresses breast cancer screening strategies for women at lower-than-average breast cancer risk. The aim of this study was to examine screening harms and benefits among women aged 50-74 years at lower-than-average bre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b13d7702e47af07a1e24d94d4ab4f968
http://www.scopus.com/inward/record.url?scp=85113715183&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85113715183&partnerID=8YFLogxK
Autor:
A. Cecile J.W. Janssens, Jeanne S. Mandelblatt, Michael Wolfson, Douglas F. Easton, Nicolien T. van Ravesteyn, Harry J. de Koning, Peter Kraft, Amy Trentham-Dietz, Clyde B. Schechter, Jacques Simard, Jeroen J. van den Broek
Publikováno v:
JNCI Journal of the National Cancer Institute
Journal of the National Cancer Institute, 113(4), 434-442. Oxford University Press
Journal of the National Cancer Institute, 113(4), 434-442. Oxford University Press
Background We assessed the clinical utility of a first-degree breast cancer family history and polygenic risk score (PRS) to inform screening decisions among women aged 30-50 years. Methods Two established breast cancer models evaluated digital mammo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcb15707e5cbc74ad4a863b42c40545c
http://www.scopus.com/inward/record.url?scp=85104047008&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85104047008&partnerID=8YFLogxK
Autor:
Esmée K. J. van der Poort, Nicolien T. van Ravesteyn, Jeroen J. van den Broek, Harry J. de Koning
Publikováno v:
Cancers, 14(12):2951. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers; Volume 14; Issue 12; Pages: 2951
Cancers; Volume 14; Issue 12; Pages: 2951
Breast cancer screening is associated with harms, such as false-positives and overdiagnoses, and, thus, novel screen tests can be considered. Liquid biopsies have been proposed as a novel method for the early detection of cancer, but low cell-free DN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c92a9e5d28abac17686e468adc079ed8
https://doi.org/10.3390/cancers14122951
https://doi.org/10.3390/cancers14122951
Autor:
Jeroen J. van den Broek
Publikováno v:
Policing: A Journal of Policy and Practice. 15:2281-2282
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b4b210c1653b76a6f61d11d8237a9bd
https://doi.org/10.1093/police/paab061
https://doi.org/10.1093/police/paab061
Autor:
Sylvia K. Plevritis, Mucahit Cevik, Natasha K. Stout, Jeanne S. Mandelblatt, Marjolein van Ballegooijen, Hui Huang, Diego F. Munoz, Harry J. de Koning, Yisheng Li, Sandra J. Lee, Nicolien T. van Ravesteyn, Jeroen J. van den Broek, Clyde B. Schechter
Publikováno v:
Medical Decision Making, 38, 112S-125S. SAGE Publishing
Background. Collaborative modeling has been used to estimate the impact of potential cancer screening strategies worldwide. A necessary step in the interpretation of collaborative cancer screening model results is to understand how model structure an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98e48e98d685fdc4610e42a9cc7d5a1f
https://doi.org/10.1177/0272989x17743244
https://doi.org/10.1177/0272989x17743244
Autor:
Harry J. de Koning, Nicolien T. van Ravesteyn, Jeroen J. van den Broek, Eveline A.M. Heijnsdijk
Publikováno v:
Medical Decision Making, 38, 54S-65S. SAGE Publishing
The MISCAN-Fadia microsimulation model uses continuous tumor growth to simulate the natural history of breast cancer and has been used extensively to estimate the impact of screening and adjuvant treatment on breast cancer incidence and mortality tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dfa6f5c1a5ef041ba6462dc4a3b4197
https://doi.org/10.1177/0272989x17711928
https://doi.org/10.1177/0272989x17711928
Autor:
Nicolien T. van Ravesteyn, Amy Trentham-Dietz, Natasha K. Stout, Harry J. de Koning, Sandra J. Lee, Jeanne S. Mandelblatt, Sue Moss, Hui Huang, Elizabeth S. Burnside, Jeroen J. van den Broek, Cong Xu, Sylvia K. Plevritis, Mehmet Ali Ergun, Juhee Song, Yisheng Li, Oguzhan Alagoz
Publikováno v:
Medical Decision Making, 38, 140S-150S. SAGE Publishing
Background. The UK Age trial compared annual mammography screening of women ages 40 to 49 years with no screening and found a statistically significant breast cancer mortality reduction at the 10-year follow-up but not at the 17-year follow-up. The o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84da934ff65ab98ea394b6c86af57c91
https://doi.org/10.1177/0272989x17718168
https://doi.org/10.1177/0272989x17718168
Autor:
Jeroen J. van den Broek, Elizabeth S. Burnside, Xuelin Huang, Donald L. Weaver, Rinaa S. Punglia, Clyde B. Schechter, Harry J. de Koning, Harald Weedon-Fekjær, Oguzhan Alagoz, Sandra J. Lee, Xiaoxue Li, Nicolien T. van Ravesteyn
Publikováno v:
Medical Decision Making, 38, 126S-139S. SAGE Publishing
Background. Ductal carcinoma in situ (DCIS) can be a precursor to invasive breast cancer. Since the advent of screening mammography in the 1980’s, the incidence of DCIS has increased dramatically. The value of screen detection and treatment of DCIS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66b33631a5934fadedea7958811029e1
https://europepmc.org/articles/PMC5862063/
https://europepmc.org/articles/PMC5862063/
Autor:
Sandra J. Lee, Xuelin Huang, Juhee Song, Jeroen J. van den Broek, Oguzhan Alagoz, Jeanne S. Mandelblatt, Sylvia K. Plevritis, Hui Huang, Nicolien T. van Ravesteyn, Cong Xu, Harry J. de Koning, Young Chandler, Mehmet Ali Ergun, Amy Trentham-Dietz, Yisheng Li, Clyde B. Schechter, Donald A. Berry, Allison W. Kurian, Aimee M. Near, Ronald E. Gangnon, Natasha K. Stout, Diego F. Munoz, Brian L. Sprague
Publikováno v:
JAMA-Journal of the American Medical Association, 319(2), 154-164. American Medical Association
Importance Given recent advances in screening mammography and adjuvant therapy (treatment), quantifying their separate and combined effects on US breast cancer mortality reductions by molecular subtype could guide future decisions to reduce disease b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4651b0bd02aec1b75cc294a35938579
https://pure.eur.nl/en/publications/08caac82-0ada-4f3f-ad8c-fd4a3fc2257e
https://pure.eur.nl/en/publications/08caac82-0ada-4f3f-ad8c-fd4a3fc2257e